# The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery

> **NCT01256502** · NA · COMPLETED · sponsor: **Sofregen Medical, Inc.** · enrollment: 160 (actual)

## Conditions studied

- Breast Reconstruction

## Interventions

- **DEVICE:** SERI® Surgical Scaffold

## Key facts

- **NCT ID:** NCT01256502
- **Lead sponsor:** Sofregen Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2012-10
- **Final completion:** 2014-04
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01256502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01256502, "The SERI® Surgical Scaffold Use in Reconstruction Post Market Study for Tissue Support and Repair in Breast Reconstruction Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01256502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*